Fortive Reports Third Quarter 2026 Results

Fortive Corp (FTV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Fortive Reports Third Quarter 2026 Results • Q3 revenue growth accelerated to 7.8% year-over-year on a reported basis and 7.2% on a core basis • Delivered Q3 GAAP diluted EPS of $0.57, up 63% year-over-year, and adjusted diluted EPS of $0.77, up 13% year-over-year •

Event · Earnings
Also in this documentGuidance · raise · $3.1–$3.14Buyback · 13%

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 28, 2026, 11:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FTV
Bullish
high confidence
Mentioned
$FTV
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FTVBullishHigh
01

Why it matters

The earnings beat and guidance raise are likely to trigger buying pressure, especially from dividend‑focused and industrial‑sector investors.

02

Market read

First‑hand earnings data and an EPS guidance raise for a mid‑cap industrial player, offering a clear short‑term trading catalyst.

03

What to watch

Potential headwinds from supply‑chain constraints or macro‑economic slowdown could temper the upside.

Relevance 7/10Novelty 9/10Timing: after‑hours release on Oct 28 2026
AlphAI · Earnings readFTV · Third Quarter 2026 · ended October 2, 2026

Fortive Reports Third Quarter 2026 Results

✓Strong quarter

Q3 revenue grew 7.8% reported and 7.2% on a core basis, adjusted EBITDA increased 9.5%, adjusted diluted EPS increased 13.2%, and Fortive raised FY 2026 adjusted diluted EPS guidance to $3.10 to $3.14.

Revenue
$1.11B
7.8% y/y
Intelligent Operating Solutions
$767M
9.8% / 9.1% (reported / core) y/y
Operating margin · GAAP
21.3 %
EPS · non-GAAP
$0.77
13.2% y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 revenueGAAP$1.11B–7.8%
Q3 2026 core revenue growthnon-GAAP7.2%–7.2%
Q3 2026 gross profitGAAP$710.6M––
Q3 2026 operating profitGAAP$235.9M––
Q3 2026 operating marginGAAP21.3 %––
Q3 2026 net earnings from continuing operationsGAAP$173M–47.4%
Q3 2026 GAAP net earnings marginGAAP15.6%–420 bps
Q3 2026 adjusted EBITDAnon-GAAP$339M–9.5%
Q3 2026 adjusted EBITDA marginnon-GAAP30.6%–50 bps
Q3 2026 diluted earnings per share from continuing operationsGAAP$0.57–62.9%
Q3 2026 adjusted diluted earnings per share from continuing operationsnon-GAAP$0.77–13.2%
Q3 2026 operating cash flow from continuing operationsGAAP$313M–6.3%
Q3 2026 free cash flow from continuing operationsnon-GAAP$284M–6.7%
Trailing twelve months GAAP operating cash flow from continuing operationsGAAP$1.18B–15.5%
Trailing twelve months free cash flow from continuing operationsnon-GAAP$1.06B–15.2%
Nine months ended October 2, 2026 salesGAAP$3.27B––
Nine months ended October 2, 2026 gross profitGAAP$2.08B––
Nine months ended October 2, 2026 operating profitGAAP$637.5M––
Nine months ended October 2, 2026 net earnings from continuing operationsGAAP$466.2M––
Nine months ended October 2, 2026 diluted earnings per share from continuing operationsGAAP$ 1.51––
Nine months ended October 2, 2026 net cash provided by operating activitiesGAAP$834.2M––

Segments

SegmentRevenueq/qy/y
Intelligent Operating SolutionsRevenue growth was reported as 9.8% and core revenue growth was 9.1%; GAAP operating margin was 29.1% and adjusted EBITDA margin was 35.8%.$767M–9.8% / 9.1% (reported / core)
Advanced Healthcare SolutionsRevenue growth was reported as 3.7% and core revenue growth was 3.1%; GAAP operating margin was 11.2% and adjusted EBITDA margin was 25.8%.$340M–3.7% / 3.1% (reported / core)

FY 2026 outlook

  • NoteAdjusted diluted earnings per share of $3.10 to $3.14

Capital returns

  • Deployed ~$300 million towards share repurchases in Q3, representing ~5 million shares or ~2% of diluted shares outstanding.
  • Completed ~$300 million of share repurchases in Q3, bringing total share repurchases since the launch of new Fortive to ~$2.3 billion, representing ~43 million shares or ~13% of shares outstanding.
  • Repurchase of common shares was $(1,000.4) million for the nine months ended October 2, 2026.
  • Payment of dividends was $(57.3) million for the nine months ended October 2, 2026.

What drove it

  • Total Q3 revenue growth was 7.8% reported and 7.2% core.
  • Intelligent Operating Solutions produced $767M of revenue, with 9.1% core revenue growth.
  • Fortive cited investments in innovation acceleration, commercial acceleration, and recurring customer value as contributors to faster revenue growth and financial performance.
  • Q3 adjusted EBITDA growth was 9.5%, and adjusted diluted EPS growth was 13.2%.
  • The company recorded a recovery within cost of sales for IEEPA tariff refund claims accepted by U.S. Customs and Border Protection; pretax IEEPA tariff refunds were $(18.0) million in the adjusted EBITDA reconciliation.

Concerns

  • Advanced Healthcare Solutions revenue grew 3.7% reported and 3.1% core, below Intelligent Operating Solutions growth.
  • Advanced Healthcare Solutions GAAP operating profit declined (10.1)% to $38M, adjusted EBITDA declined (4.8)% to $88M, and adjusted EBITDA margin declined (230) bps to 25.8%.
  • Interest expense, net was $ 38.8 million in Q3 2026 compared with $ 25.4 million in Q3 2025.
  • Long-term debt was $ 3,514.2 million as of October 2, 2026, compared with $ 2,306.5 million as of December 31, 2025.

What to watch

  • Delivery against FY 2026 adjusted diluted EPS guidance of $3.10 to $3.14.
  • Whether Intelligent Operating Solutions sustains 9.1% core revenue growth.
  • Advanced Healthcare Solutions revenue growth and recovery in GAAP and adjusted EBITDA margins.
  • The effect of the IEEPA tariff-refund recovery and capitalized software impairment on reported and adjusted results.
  • Further share repurchases following ~$2.3 billion repurchased since the launch of new Fortive.

Balance sheet and cash flow

  • Cash and equivalents were $ 377.3 million as of October 2, 2026, compared with $ 375.5 million as of December 31, 2025.
  • Long-term debt was $ 3,514.2 million as of October 2, 2026, compared with $ 2,306.5 million as of December 31, 2025.
  • Current portion of long-term debt was $ — as of October 2, 2026, compared with $ 899.5 million as of December 31, 2025.
  • Nine-month net cash provided by operating activities was $ 834.2 million, compared with $ 717.3 million.
  • Nine-month purchases of property, plant and equipment were $(84.2) million, compared with $(74.7) million.
  • Nine-month cash paid for acquisitions, net of cash received was $(58.1) million.
  • Nine-month proceeds from borrowings, net of issuance costs, were $ 1,088.0 million, while repayment of borrowings was $(1,192.9) million.

Analysis

Fortive reported Q3 2026 revenue of $1.11 billion, up 7.8% year-over-year on a reported basis and 7.2% on a core basis. Intelligent Operating Solutions was the primary growth contributor, with $767M of revenue and 9.1% core growth. Advanced Healthcare Solutions generated $340M of revenue, with 3.1% core growth. The company characterized the quarter as its fifth consecutive quarter of double-digit adjusted EPS growth.

Profitability improved at the consolidated level. GAAP net earnings from continuing operations increased 47.4% to $173M, GAAP net earnings margin rose 420 bps to 15.6%, and adjusted EBITDA increased 9.5% to $339M. Adjusted EBITDA margin rose 50 bps to 30.6%. GAAP diluted EPS increased 62.9% to $0.57, while adjusted diluted EPS increased 13.2% to $0.77. The reconciliation includes $(18.0) million of pretax IEEPA tariff refunds and $6.2 million of pretax capitalized software impairment in Q3 2026.

Segment margins diverged. Intelligent Operating Solutions increased GAAP operating margin by 320 bps to 29.1% and adjusted EBITDA margin by 120 bps to 35.8%. Advanced Healthcare Solutions reported a 170 bps decline in GAAP operating margin to 11.2% and a 230 bps decline in adjusted EBITDA margin to 25.8%; its GAAP operating profit and adjusted EBITDA both declined year-over-year. This segment profitability trend is the principal counterweight to the consolidated growth and margin performance.

Cash generation remained positive, with Q3 GAAP operating cash flow of $313M and free cash flow of $284M. Trailing twelve months GAAP operating cash flow was $1,177M and free cash flow was $1,062M. Fortive deployed ~$300 million to Q3 share repurchases, while nine-month repurchases totaled $(1,000.4) million and dividend payments totaled $(57.3) million. Cash and equivalents were $377.3 million and long-term debt was $3,514.2 million at October 2, 2026.

Management raised FY 2026 adjusted diluted EPS guidance to $3.10 to $3.14 and did not provide revenue, margin, operating-expense, or tax-rate guidance in the release. The guide reflects management's stated confidence in the business trajectory and year-to-date results. With no previous outlook supplied, performance versus prior guidance cannot be assessed from the provided documents.

Management, verbatim

Q3 was another quarter of strong and accelerating performance for Fortive. We delivered over 7% core growth, approximately 10% adjusted EBITDA growth, and 13% adjusted EPS growth, representing our fifth consecutive quarter of double-digit adjusted EPS growth.

Olumide Soroye, President and CEO

We are raising our full-year adjusted EPS guidance to $3.10 to $3.14, reflecting our strong year-to-date performance and our confidence in the trajectory of the business.

Olumide Soroye, President and CEO

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided; therefore, no comparison of actual results with prior guidance is available.
  • FY 2026 revenue guidance was not provided.
  • FY 2026 gross-margin guidance was not provided.
  • FY 2026 operating-expense guidance was not provided.
  • FY 2026 tax-rate guidance was not provided.
  • Q3 2026 gross margin was not provided.
  • Q3 2026 prior-quarter comparisons and sequential changes for reported metrics were not provided.
  • Q3 2026 GAAP effective tax rate was not provided.
  • A Q3 2026 adjusted net earnings year-over-year percentage change was not provided.
  • A Q3 2026 total GAAP operating-profit year-over-year percentage change was not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Fortive's Q3 2026 earnings release via an SEC Form 8‑K provides the first public disclosure of its quarterly results and updated FY guidance.

Company-level read

Ticker impact

$FTVBullishHigh confidence
Context

Fortive raised its FY 2026 adjusted EPS guidance to $3.10‑$3.14, up ~15% YoY, after reporting Q3 revenue growth of 7.8% and GAAP EPS of $0.57.

Expected impact

likely upward pressure as investors price in higher earnings expectations

Evidence & confidence

The company disclosed a material increase in EPS guidance alongside robust revenue and earnings growth, a clear catalyst for short‑term price appreciation.

Market effects

Strong performance may lift the industrial automation and healthcare technology segments where Fortive operates.

Positive for U.S. industrials, may boost related peers in the same sector.

Limited to investors tracking U.S. industrial conglomerates.

Counterpoint

If the guidance raise is already priced in, the stock could face a short‑term pullback.

Key entities

  • Fortive Corp

    Industrial technology conglomerate reporting Q3 2026 results.

  • Olumide Soroye

    President and CEO of Fortive, quoted on the earnings release.

Every FTV earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$FTVMed

Is Ingersoll Rand A Better Way Than Fortive To Own Industrial Demand?

Fortive (FTV) and Ingersoll Rand (IR) both raised 2026 forecasts. FTV increased adjusted EPS to $3.12, citing strong performance. IR raised revenue growth to 6.3% and EPS to $3.64, attributing it to lower tax rate and share count. FTV has higher margins (63.5%) and focuses on buybacks, while IR emphasizes aftermarket sales and acquisitions, with lower margins (43.1%).

$FTVMed

Mizuho raises Fortive stock price target to $55 on earnings beat

Mizuho raised its price target for Fortive (FTV) to $55 from $51, keeping an Underperform rating. Fortive reported adjusted EPS of $0.77, beating estimates of $0.71, with 13% YoY growth. Core growth was 7.2%, and adjusted EBITDA margin was 30.6%. The company raised its 2026 EPS guidance to $3.10-$3.14. The stock is up 16.5% YTD. Truist also raised its target to $65, citing strong growth and margins.

$FTVHighAI 8/10

Fortive Corp (FTV) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Fortive Corp (FTV) reported Q3 2026 earnings, highlighting a decline in adjusted gross margin to 63% due to product mix. The Advanced Healthcare Solutions segment saw EBITDA margin contract 230 bps. CEO Soroye expressed confidence in long-term growth despite inflationary pressures and a Q4 revenue headwind of $15-$20M. The company is investing in innovation and data center sales, with core growth tracking above 5% for the year.